NCT05879367 Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma Status RECRUITING Phase PHASE1
NCT05781321 Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05765812 A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT05728619 HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05698524 A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma Status RECRUITING Phase PHASE1
NCT05691491 Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness Status RECRUITING Phase PHASE1/PHASE2
NCT05685004 Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05663125 LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas Status UNKNOWN Phase PHASE1/PHASE2
NCT05634707 Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05629702 ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids Status RECRUITING Phase PHASE2
NCT05600491 A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme Status RECRUITING Phase PHASE3
NCT05588453 Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain Status RECRUITING Phase PHASE1/PHASE2
NCT05440786 CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05439278 Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma Status RECRUITING Phase PHASE3
NCT05432804 Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment Status RECRUITING Phase PHASE1/PHASE2
NCT05432791 Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05429502 Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors Status TERMINATED Phase PHASE1
NCT05384821 Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) Status RECRUITING Phase PHASE1/PHASE2